River Financial

Companies

River Financial is a Bitcoin-only brokerage and financial services company focused on long-term Bitcoin accumulation. Founded in 2019 by Alex Leishman, River offers zero-fee recurring Bitcoin purchases, cold storage custody, a Bitcoin IRA, and wealth management services. River is backed by Stillmark, Goldfinch Partners, and other Bitcoin-aligned investors.

Details

Ceo: Alex Leishman
Public: No
Sector: financial_services
Known For: Bitcoin-only brokerage, zero-fee recurring buys, River IRA, cold storage custody
Client Btc: 19660
Bitcoin Only: Yes
Company Type: Bitcoin-Only Brokerage / Financial Services
Founded Year: 2019
Headquarters: San Francisco, California, USA
Holdings Date: 2025-04
Holdings Source: River public financials, April 2025
Bitcoin Holdings: 342
Bitcoin Strategy: Holds Bitcoin as corporate equity reserves above client liabilities. Published public financials in April 2025 showing 20,002 BTC total custody against 19,660 BTC client liabilities, with ~342 BTC as River's own equity position.
Total Custody Btc: 20002
Bitcoin Holdings Note: Private company — holds operational BTC for client services. No public treasury disclosure. Bitcoin-only focus.

Links

twitter

More Companies

Strategy (formerly MicroStrategy)

Strategy (Nasdaq: MSTR), formerly MicroStrategy, is the world's largest corporate Bitcoin holder. Founded by Michael Saylor, the company rebranded in 2025 to reflect its identity as a Bitcoin treasury company. It holds over 500,000 BTC accumulated through equity and debt financing, pioneering the corporate Bitcoin standard that inspired hundreds of companies worldwide.

ACINQ

ACINQ is a French Bitcoin infrastructure company and the developer of Eclair, one of the three major Lightning Network implementations. Founded in 2014, ACINQ builds Phoenix Wallet (a non-custodial Lightning wallet) and operates the ACINQ Lightning node, one of the most well-connected nodes on the Lightning Network.

Acurx Pharmaceuticals

Acurx Pharmaceuticals (NASDAQ: ACXP) is a US biopharmaceutical company that made headlines in November 2021 by adopting Bitcoin as its primary treasury reserve asset — one of the first pharmaceutical companies to do so. The company approved purchasing $1 million in Bitcoin and has continued to hold BTC alongside its drug development pipeline focused on antibiotics. Notable for crossing industry boundaries to embrace the Bitcoin standard.